Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Czechia
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleClinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
- Where
- Prague
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- icometrix
See details and how to joinNCT06280755